Canada markets open in 7 hours 48 minutes

MYND Lifesciencs Inc. (MYNDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07290.0000 (0.00%)
At close: 10:03AM EDT

MYND Lifesciencs Inc.

733 Finns Road
Kelowna, BC V1X 5B7
Canada
403 559 6779
https://www.myndsciences.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Wilfred A. JefferiesCo-Founder, Chairman & Chief Science OfficerN/AN/A1958
Dr. Lyle Oberg M.D.Co-Founder, CEO & DirectorN/AN/A1960
Mr. Lih-Ming TamInterim CFO & Sr. ControllerN/AN/AN/A
Dr. Chaahat S.B SinghSr. Operations & Research Mang.N/AN/AN/A
Mr. Luke WarkentinVP of Corp. Devel.N/AN/AN/A
Dr. Iryna Saranchova Ph.D.Chief Clinical OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company was incorporated in 2018 and is headquartered in Kelowna, Canada.

Corporate Governance

MYND Lifesciencs Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.